《Translational Cancer Research》重点专注发布ONCOLOGY领域的新研究,旨在促进和传播该领域相关的新技术和新知识。鼓励该领域研究者详细地发表他们的高质量实验研究和理论结果。该杂志创刊至今,在ONCOLOGY领域,有较高影响力,对来稿文章质量要求较高,稿件投稿过审难度较大。欢迎广大同领域研究者投稿该杂志。
CiteScore | SJR | SNIP | CiteScore排名 | |||
---|---|---|---|---|---|---|
2.1 | 0.422 | 0.39 | 学科类别 | 分区 | 排名 | 百分位 |
大类:大类:Medicine
小类:小类:Radiology,NuclearMedicineandImaging
|
Q3 | 209/333 | 37% | |||
大类:大类:Medicine
小类:小类:Oncology
|
Q3 | 271/404 | 33% | |||
大类:大类:Medicine
小类:小类:CancerResearch
|
Q4 | 183/230 | 20% |
按JIF指标学科分区 | 收录子集 | 分区 | 排名 | 百分位 |
---|---|---|---|---|
学科:ONCOLOGY | SCIE | Q4 | 259 / 322 | 19.7% |
按JCI指标学科分区 | 收录子集 | 分区 | 排名 | 百分位 |
---|---|---|---|---|
学科:ONCOLOGY | SCIE | Q4 | 287 / 322 | 11.02% |
文章名称
引用次数
Exosomal lncRNAs as new players in cell-to-cell communication
36
Downregulation of hexokinase 2 improves radiosensitivity of breast cancer
16
The role of deep learning and radiomic feature extraction in cancer-specific predictive modelling: a review
12
Circular RNAs and competing endogenous RNA (ceRNA) networks
12
EGFR first- and second-generation TKIs-there is still place for them in EGFR-mutant NSCLC patients
9
Exosomes as critical mediators of cell-to-cell communication in cancer pathogenesis and their potential clinical application
8
EGFR exon 19 deletion switch and development of p.L792Q mutation as a new resistance mechanism to osimertinib: a case report and literature review
7
Expression and prognostic value of PD-L1 and PD-L2 in ovarian cancer
7
New techniques for sentinel node biopsy in breast cancer
6
The future is now: beyond first line systemic therapy in hepatocellular carcinoma
6





